Business
Know the Business
Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
Suzlon is a vertically integrated Indian wind turbine OEM riding the second-largest cyclical recovery in its history. The story today is not technology — it's that a once-bankrupt company has rebuilt distribution, balance sheet, and product, and India's wind market is finally sized to absorb its 4.5 GW of low-cost manufacturing capacity. The market is pricing in flawless execution at 10x book; the asymmetric risks are receivables, project-execution slippage, and the next downcycle in tariff-driven bid demand — none of which the current narrative reflects.
1. How This Business Actually Works
Suzlon sells wind turbines, then earns an annuity for 20+ years servicing them. Everything else — EPC, forging, project development — exists to win the turbine sale and protect the lifetime cash stream attached to it.
The economic engine has three layers, and they have very different margin profiles. Knowing the mix is more useful than any P&L line item.
The WTG line is volume-and-mix driven. EBITDA margin moved from 13.7% to 16.0% inside two quarters of FY26 purely because of (a) which customer was supplied — average sales price is contract-specific — and (b) what share was supplied as EPC versus turbine-only. Project (EPC) revenue carries lower margin than turbine supply but locks in scope and crowds out competitors at the bid stage. Suzlon is deliberately raising EPC mix from 20% to a 50% target by 2028, which dilutes WTG margin but expands revenue per MW by ~2.5x.
OMS is the quietly important business. Suzlon manages 15.5+ GW of its own installed fleet under service contracts, with machine availability above 95%. Renom (76% acquisition completing in two tranches; $79M) extended the OMS franchise to 32 GW of non-Suzlon assets in India — turning a captive aftermarket into a multi-brand independent service provider. OMS contributes a quarter of revenue at materially higher margin and far lower working capital than WTG, and it grows mechanically as the installed base grows.
Operating leverage is the other lever. CEO Chalasani states breakeven was rebuilt from 1,300–1,400 MW to 650–700 MW. The 9M FY26 delivery run-rate of 1,625 MW is roughly 2.4x breakeven — every incremental MW now drops disproportionately to EBITDA. This is why FY25 ROCE jumped to 33% with revenue still below FY14 levels in absolute terms.
What truly drives incremental profit:
- Order book conversion velocity — turbines sit in execution for 4–7 quarters; faster conversion = higher capital turnover.
- Customer mix in any given quarter — large strategic accounts (e.g., Tata Power 838 MW) carry better realization than small captives.
- Land and grid evacuation readiness — historically the binding constraint on commissioning.
The Indian wind industry is using only ~20% of its installed 20 GW annual WTG manufacturing capacity (per Suzlon CEO). Suzlon's 4.5 GW of capacity at 70%+ utilization gives it a fixed-cost-absorption advantage that smaller peers and global entrants cannot easily replicate inside India.
2. The Playing Field
There is only one true Indian WTG-manufacturing peer (Inox Wind). The rest are downstream IPPs that buy turbines or industrial conglomerates with adjacent exposure. Treating them as comparables on multiples without that distinction is a classic analyst error.
Suzlon trades at 7.1x sales versus Inox Wind's 5.0x — the only fair comparison. The 40% premium is mostly the OMS annuity and the cleaner balance sheet. Adani Green and Tata Power operate on a different chassis: they are IPPs that finance and own generation assets, so their earnings scale with installed capacity and tariff, not turbine-build volume. Comparing P/E across these names is misleading; revenue multiples and ROCE are the only honest cross-cut.
What "good" looks like in WTG manufacturing globally is a 15–18% steady-state EBITDA margin, 25%+ ROCE through cycle, and book-to-bill above 1.0x. Suzlon's 9M FY26 numbers (18% EBITDA margin, 33% ROCE, 1.9x book-to-bill) are at peak-cycle highs — not a steady state.
3. Is This Business Cyclical?
Severely. Suzlon's revenue collapsed from $3,407M in FY14 to $393M in FY20 — an 88% peak-to-trough drawdown — and accumulated losses by FY20 wiped out the equity base. Anyone modeling this company off three years of recovery numbers is making a category error.
The cycle hits in five places, not one:
Demand. Tied to PPA awards. Central bidding (SECI) has paused on PPA-signing delays. State bidding (GUVNL, MPUVNL) is filling the gap, plus C&I/captive (51% of current order book) and PSU (13%). Concentration in central tariff bids is what killed FY18–FY20.
Working capital. This is the brutal one. Inventory days peaked at 503 in FY21; debtor days at 168 in FY20. Cash conversion cycle hit 315 days. Today: 145 days, but debtors are creeping up again (102 → 130 over two years). The FY26 receivable balance is $640M against revenue of roughly $1,640M full-year — DSO of 145+ days, with $234M of that subject to milestone completion before it becomes due.
Margins. Two-quarter swings of 200–300 bps purely on customer mix and EPC share. Not a stable margin profile.
Capital markets access. Suzlon survived only because of repeated equity issuances and debt restructurings (CDR, SDR, S4A, the 2023 QIP). The FY23 net profit of $351M was largely a non-cash debt-restructuring gain (other income $333M).
Project execution. Land, grid evacuation, customer financing — non-financial constraints that turn revenue into receivables and receivables into write-offs.
The balance sheet repair is the single most important fact in the equity story. Borrowings went from $2,849M (FY14) to $38M (FY25). Net cash now $182M. Reserves swung from -$1,593M (FY20) to +$395M (FY25). This is what gives the company a second life — not the order book.
4. The Metrics That Actually Matter
Forget P/E. The five numbers below carry the entire equity story; everything else is downstream of them.
Order book ÷ capacity is the single most useful number. At 6.4 GW order book against 4.5 GW capacity (1.4 years of work), the supply line is full — but not so full that bottlenecks slip schedules. Once book-to-bill stays under 1.0x for two consecutive quarters, the cycle has rolled over.
Quarterly deliveries matter more than revenue because they convert the order book to cash and run through the breakeven calculus. Sub-300 MW quarterly deliveries put the company back near breakeven; 600+ MW puts it at peak operating leverage.
WTG EBITDA margin volatility tells you who has pricing power. Suzlon's 200–300 bps quarterly swing on customer mix says it does not have stable pricing — it has stable cost structure with variable realizations.
OMS AUM is the part of the business that doesn't care about the cycle. The market underweights this because the WTG segment is louder.
Debtor + inventory days is the leading indicator of trouble. Watch this monthly during downturns; in FY18–FY19 it broke before the P&L did.
Net cash position is the survival metric. The single biggest reason this company has any equity value today is that the 2023 QIP reset the balance sheet from terminal to defensible.
5. What I'd Tell a Young Analyst
This is a high-quality business at a moment that is not high-quality to be entering it. The economics are good because the cycle is up and capacity utilization is rising; both will mean-revert.
Three things to watch each quarter:
- Book-to-bill ratio — if it falls below 1.0x for two quarters, the order book is shrinking and operating leverage starts working in reverse.
- Receivables aging — Suzlon's quarterly call now discloses the >1-year bucket. Anything above $58M there is a warning.
- EPC share progression — the 50% target by 2028 means margins should compress predictably; if margins hold flat as EPC mix rises, something is being booked aggressively.
Two things the market is likely underestimating:
- The Renom acquisition gives Suzlon access to 32 GW of competitor-installed turbines for service. OMS scales without capex; this is the most valuable mix-shift the company has on the table.
- The forging/foundry business (SE Forge) at 33% YoY growth and ~20% EBITDA margin is being treated as a rounding error. It is exporting castings to defense and railways and benefits from a separate end-market cycle.
Two things the market is likely overestimating:
- Pricing power. A 13.7% WTG margin in a record-execution quarter, after multiple price hikes, is not the margin profile of a moat-protected business. Inox Wind's price competition is real and re-emerging.
- Earnings durability. FY25 net profit was inflated by a -43% effective tax rate (deferred tax asset recognition). Normalize this and FY25 PAT is ~$164M, not $242M. The reported 23.9x P/E becomes ~35x.
What would change the thesis: a WTG EBITDA margin sustainably above 18% would suggest pricing power has emerged; OMS AUM growing 30%+ on Renom integration would prove the annuity scaling story; or a sub-300 MW delivery quarter would suggest the cycle has turned. None of those is in consensus.
The question is not whether Suzlon executes — it has been executing — but whether the multiple already prices that execution, and what the company looks like at trough operating leverage. The answer to the second question is the FY18–FY20 P&L, and that history sits one bid-cycle away.